BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ishigami S, Arigami T, Uchikado Y, Setoyama T, Kita Y, Sasaki K, Okumura H, Kurahara H, Kijima Y, Harada A. IL-32 expression is an independent prognostic marker for gastric cancer. Med Oncol. 2013;30:472. [PMID: 23479179 DOI: 10.1007/s12032-013-0472-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Erturk K, Tastekin D, Serilmez M, Bilgin E, Bozbey HU, Vatansever S. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer. Tumor Biol 2016;37:405-12. [DOI: 10.1007/s13277-015-3829-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
2 Xia F, Yu Z, Deng A, Gao G. Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma. Exp Biol Med (Maywood) 2021;:15353702211053801. [PMID: 34743576 DOI: 10.1177/15353702211053801] [Reference Citation Analysis]
3 Kim MS, Kang JW, Park YS, Lee DH, Bak Y, Kwon T, Yoon DY. IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1. Oncotarget 2015;6:4394-405. [PMID: 25726525 DOI: 10.18632/oncotarget.3013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
4 Piktel E, Niemirowicz K, Wnorowska U, Wątek M, Wollny T, Głuszek K, Góźdź S, Levental I, Bucki R. The Role of Cathelicidin LL-37 in Cancer Development. Arch Immunol Ther Exp (Warsz) 2016;64:33-46. [PMID: 26395996 DOI: 10.1007/s00005-015-0359-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
5 Lee J, Kim KE, Cheon S, Song JH, Houh Y, Kim TS, Gil M, Lee KJ, Kim S, Kim D, Hur DY, Yang Y, Bang SI, Park HJ, Cho D. Interleukin-32α induces migration of human melanoma cells through downregulation of E-cadherin. Oncotarget 2016;7:65825-36. [PMID: 27589563 DOI: 10.18632/oncotarget.11669] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
6 Pavlovic M, Gajovic N, Jurisevic M, Mitrovic S, Radosavljevic G, Pantic J, Arsenijevic N, Jovanovic I. Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer. Gastroenterol Res Pract 2018;2018:6578273. [PMID: 30402092 DOI: 10.1155/2018/6578273] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Player A, Abraham N, Burrell K, Bengone IO, Harris A, Nunez L, Willaims T, Kwende S, Walls W. Identification of candidate genes associated with triple negative breast cancer. Genes Cancer 2017;8:659-72. [PMID: 28966727 DOI: 10.18632/genesandcancer.147] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
8 Xuan W, Huang W, Wang R, Chen C, Chen Y, Wang Y, Tan X. Elevated circulating IL-32 presents a poor prognostic outcome in patients with heart failure after myocardial infarction. Int J Cardiol 2017;243:367-73. [PMID: 28747035 DOI: 10.1016/j.ijcard.2017.03.065] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
9 Han S, Yang Y. Interleukin-32: Frenemy in cancer? BMB Rep 2019;52:165-74. [PMID: 30638183 [PMID: 30638183 DOI: 10.5483/bmbrep.2019.52.3.019] [Cited by in Crossref: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Player A, Oguamanam T, Okanmelu J, Burrell K, Hollomon M. Preliminary characterization of IL32 in basal-like/triple negative compared to other types of breast cell lines and tissues. BMC Res Notes 2014;7:501. [PMID: 25100201 DOI: 10.1186/1756-0500-7-501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
11 Park JS, Choi SY, Lee J, Lee M, Nam ES, Jeong AL, Lee S, Han S, Lee M, Lim J, Yoon DY, Kwon Y, Yang Y. Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway. Cell Oncol 2013;36:493-503. [DOI: 10.1007/s13402-013-0154-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
12 Lin J, Xu R, Hu L, You J, Jiang N, Li C, Che C, Wang Q, Xu Q, Li J, Zhao G. Interleukin-32 induced thymic stromal lymphopoietin plays a critical role in the inflammatory response in human corneal epithelium. Cell Signal 2018;49:39-45. [PMID: 29803543 DOI: 10.1016/j.cellsig.2018.05.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Aass KR, Kastnes MH, Standal T. Molecular interactions and functions of IL-32. J Leukoc Biol 2021;109:143-59. [PMID: 32869391 DOI: 10.1002/JLB.3MR0620-550R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yang J, Jian Z, Shen P, Bai Y, Tang Y, Wang J. Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population. Dis Markers 2020;2020:8860445. [PMID: 33204366 DOI: 10.1155/2020/8860445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Sloot YJE, Smit JW, Joosten LAB, Netea-Maier RT. Insights into the role of IL-32 in cancer. Semin Immunol 2018;38:24-32. [PMID: 29747940 DOI: 10.1016/j.smim.2018.03.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
16 Nicholl MB, Chen X, Qin C, Bai Q, Zhu Z, Davis MR, Fang Y. IL-32α has differential effects on proliferation and apoptosis of human melanoma cell lines: IL-32. J Surg Oncol 2016;113:364-9. [DOI: 10.1002/jso.24142] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
17 Diakowska D, Krzystek-Korpacka M. Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance. Diagnostics (Basel) 2020;10:E785. [PMID: 33020452 DOI: 10.3390/diagnostics10100785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Heinhuis B, Plantinga TS, Semango G, Küsters B, Netea MG, Dinarello CA, Smit JW, Netea-maier RT, Joosten LA. Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines. CARCIN 2016;37:197-205. [DOI: 10.1093/carcin/bgv172] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
19 Chen J, Wang S, Su J, Chu G, You H, Chen Z, Sun H, Chen B, Zhou M. Interleukin-32α inactivates JAK2/STAT3 signaling and reverses interleukin-6-induced epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer cells. Onco Targets Ther 2016;9:4225-37. [PMID: 27471397 DOI: 10.2147/OTT.S103581] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
20 Chang WJ, Du Y, Zhao X, Ma LY, Cao GW. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol 2014; 20(16): 4586-4596 [PMID: 24782611 DOI: 10.3748/wjg.v20.i16.4586] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 97] [Article Influence: 12.0] [Reference Citation Analysis]
21 Brücher BL, Lang F, Jamall IS, Bandapalli OR. NF- κ B signaling and crosstalk during carcinogenesis. 4open 2019;2:13. [DOI: 10.1051/fopen/2019010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
22 Cui Y, Sun Z, Li X, Leng C, Zhang L, Fu X, Li L, Zhang X, Chang YU, Nan F, Li Z, Yan J, Zhang M, Li W, Wang G, Zhang D, Ma Y. Expression and clinical significance of cyclooxygenase-2 and interleukin-32 in primary gastric B-cell lymphoma. Oncol Lett 2016;11:693-8. [PMID: 26870269 DOI: 10.3892/ol.2015.3950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
23 Feng T, Sun L, Qi W, Pan F, Lv J, Guo J, Zhao S, Ding A, Qiu W. Prognostic significance of Tspan9 in gastric cancer. Mol Clin Oncol 2016;5:231-6. [PMID: 27588187 DOI: 10.3892/mco.2016.961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
24 Fukamachi T, Ikeda S, Saito H, Tagawa M, Kobayashi H. Expression of acidosis-dependent genes in human cancer nests. Mol Clin Oncol 2014;2:1160-6. [PMID: 25279216 DOI: 10.3892/mco.2014.344] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
25 Zhai JM, An YH, Wang W, Fan YG, Yao GL. IL-32 expression indicates unfavorable prognosis in patients with colon cancer. Oncol Lett 2019;17:4655-60. [PMID: 30988822 DOI: 10.3892/ol.2019.10136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]